Workflow
Nevro(NVRO)
icon
Search documents
Nevro(NVRO) - 2021 Q2 - Earnings Call Transcript
2021-08-05 07:15
Nevro Corp. (NYSE:NVRO) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Julie Dewey – Vice President-Investor Relations and Corporate Communications Keith Grossman – Chairman, Chief Executive Officer and President Rod MacLeod – Chief Financial Officer Conference Call Participants Larry Biegelsen – Wells Fargo Bob Hopkins – Bank of America Robbie Marcus – JPMorgan Joanne Wuensch – Citi Matt Taylor – UBS Cecilia Furlong – Morgan Stanley Adam Maeder – Piper Sandler Chris Pasqual ...
Nevro(NVRO) - 2021 Q2 - Quarterly Report
2021-08-04 20:53
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) (I.R.S ...
Nevro(NVRO) - 2021 Q1 - Earnings Call Transcript
2021-05-09 18:02
Nevro Corp. (NYSE:NVRO) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Julie Dewey - VP of IR and Corporate Communications Keith Grossman - Chairman, CEO and President Rod MacLeod - Chief Financial Officer Conference Call Participants Bob Hopkins - Bank of America Robbie Marcus - JPMorgan Kaila Krum - Truist Securities Cecilia Furlong - Morgan Stanley Kevin Farshchi - Wells Fargo Matt Taylor - UBS Danielle Antalffy - SVB Leerink Bill Plovanic - Canaccord Adam Maeder - Piper San ...
Nevro(NVRO) - 2021 Q1 - Quarterly Report
2021-05-05 20:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) (I.R. ...
Nevro(NVRO) - 2020 Q4 - Earnings Call Presentation
2021-02-26 21:51
4Q and Full-Year 2020 Earnings Presentation 1 February 24, 2021 IIIIIIII neviro Forward-looking Statements | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...
Nevro(NVRO) - 2020 Q4 - Earnings Call Transcript
2021-02-25 03:04
Nevro Corp (NYSE:NVRO) Q4 2020 Earnings Conference Call February 24, 2021 4:30 PM ET Company Participants Julie Dewey - VP, IR & Corporate Communications Keith Grossman - Chairman, CEO & President Roderick MacLeod - CFO Conference Call Participants Adam Maeder - Piper Sandler & Co. William Plovanic - Canaccord Genuity Robert Hopkins - Bank of America Merrill Lynch David Lewis - Morgan Stanley Allen Gong - JPMorgan Chase & Co. Danielle Antalffy - SVB Leerink Kaila Krum - Truist Securities Young Li - UBS Inve ...
Nevro(NVRO) - 2020 Q4 - Annual Report
2021-02-24 21:55
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2020 | Title of each class | Trading Symbol | Name of exchange on which registered | | --- | --- | --- | | Common Stock, par value $0.001 per share | NVRO | New York Stock Exchange | or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 001-36715 ...
Nevro(NVRO) - 2020 Q3 - Earnings Call Transcript
2020-11-08 18:56
Nevro Corp. (NYSE:NVRO) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Keith Grossman - Chairman, Chief Executive Officer & President Roderick MacLeod - Chief Financial Officer Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marcus - JPMorgan Chase & Co. David Lewis - Morgan Stanley Robert Hopkins - Bank of America Merrill Lynch Danielle Antalffy - SVB Leerink Joanne Wuensch - Citigroup Kaila Krum - Truist Securities Margaret Kaczor - Willia ...
Nevro(NVRO) - 2020 Q3 - Quarterly Report
2020-11-05 21:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 56-2568057 ( ...
Nevro(NVRO) - 2020 Q2 - Earnings Call Transcript
2020-08-06 05:30
Nevro Corp (NYSE:NVRO) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Juliet Cunningham - VP, IR Keith Grossman - Chairman, CEO & President Roderick MacLeod - CFO Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marcus - JPMorgan Chase & Co. David Lewis - Morgan Stanley Margaret Kaczor - William Blair & Company Robert Hopkins - Bank of America Merrill Lynch Joanne Wuensch - Citigroup Danielle Antalffy - SVB Leerink Kaila Krum - Truist Securitie ...